Medical devices, healthcare technology and the business of care
510(k) clearance · K261305

MICSI-PET

Microstructure Imaging, Inc. · Decision date Sep 11, 2026

MEDTECHLEDGER EXPLANATIONK261305

What did the FDA decide?

FDA recorded a substantially equivalent (SESE) decision for MICSI-PET, a 510(k) submitted by Microstructure Imaging, Inc. of Brooklyn, New York, with a decision date of September 11, 2026 and receipt date of April 20, 2026. The submission is K261305, a traditional 510(k) reviewed by FDA rather than a third party, listed under regulation 892.1200 with classification product code KPS and subsequent product code LLZ in the radiology specialty. SESE means clearance to market, not premarket approval.

The reviewed document describes MICSI-PET Super-Resolution as software as a medical device intended to enhance positron emission tomography brain images, and states the device is similar to its predicate with the same intended use environment and user. The public record does not identify the predicate device, the specific image-processing changes, or performance data supporting equivalence; those details remain in the underlying FDA documents. No clinical or diagnostic claims are established by this clearance.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Radiology
Decision date
Sep 11, 2026

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K261305
Regulatory pathway
510(k) premarket notification
Product code
KPS
Decision code
SESE
Decision date
Sep 11, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: System, Tomography, Computed, Emission.

Product code
KPS
FDA device class
2

FDA decision timeline

  1. K261305 received

    Application receipt date recorded by FDA.

  2. K261305 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

No additional submissions with a verified PMA or product-code relationship are linked here.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Microstructure Imaging, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Brooklyn, NY

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records